These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 28741092)
1. A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres. Ni YL; Hsieh CH; Kim SH; Wang JP; Su CL; Yao CF; Fang K Apoptosis; 2017 Oct; 22(10):1235-1245. PubMed ID: 28741092 [TBL] [Abstract][Full Text] [Related]
2. An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions. Liu CY; Wu PT; Wang JP; Fan PW; Hsieh CH; Su CL; Chiu CC; Yao CF; Fang K Apoptosis; 2015 Nov; 20(11):1471-82. PubMed ID: 26349782 [TBL] [Abstract][Full Text] [Related]
3. An indolylquinoline derivative activates DNA damage response and apoptosis in human hepatocellular carcinoma cells. Liu CY; Hsieh CH; Kim SH; Wang JP; Ni YL; Su CL; Yao CF; Fang K Int J Oncol; 2016 Dec; 49(6):2431-2441. PubMed ID: 27748837 [TBL] [Abstract][Full Text] [Related]
4. Teroxirone motivates apoptotic death in tumorspheres of human lung cancer cells. Ni YL; Hsieh CH; Wang JP; Fang K Chem Biol Interact; 2018 Aug; 291():137-143. PubMed ID: 29908167 [TBL] [Abstract][Full Text] [Related]
5. 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo. Ahn MY; Kim TH; Kwon SM; Yoon HE; Kim HS; Kim JI; Kim YC; Kang KW; Ahn SG; Yoon JH Eur J Pharm Sci; 2015 Nov; 79():122-31. PubMed ID: 26342773 [TBL] [Abstract][Full Text] [Related]
6. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer. Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735 [TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells. Di Martile M; Desideri M; De Luca T; Gabellini C; Buglioni S; Eramo A; Sette G; Milella M; Rotili D; Mai A; Carradori S; Secci D; De Maria R; Del Bufalo D; Trisciuoglio D Oncotarget; 2016 Mar; 7(10):11332-48. PubMed ID: 26870991 [TBL] [Abstract][Full Text] [Related]
8. BPIQ, a novel synthetic quinoline derivative, inhibits growth and induces mitochondrial apoptosis of lung cancer cells in vitro and in zebrafish xenograft model. Chiu CC; Chou HL; Chen BH; Chang KF; Tseng CH; Fong Y; Fu TF; Chang HW; Wu CY; Tsai EM; Lin SR; Chen YL BMC Cancer; 2015 Dec; 15():962. PubMed ID: 26672745 [TBL] [Abstract][Full Text] [Related]
10. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models. Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271 [TBL] [Abstract][Full Text] [Related]
11. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022 [TBL] [Abstract][Full Text] [Related]
12. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer. Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244 [TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors. Wang YY; Lv YF; Lu L; Cai L Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795 [TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467 [TBL] [Abstract][Full Text] [Related]
15. Autophagy inhibition enhances isorhamnetin‑induced mitochondria‑dependent apoptosis in non‑small cell lung cancer cells. Ruan Y; Hu K; Chen H Mol Med Rep; 2015 Oct; 12(4):5796-806. PubMed ID: 26238746 [TBL] [Abstract][Full Text] [Related]
16. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells. Wang J; Luo B; Li X; Lu W; Yang J; Hu Y; Huang P; Wen S Cell Death Dis; 2017 Jun; 8(6):e2887. PubMed ID: 28640251 [TBL] [Abstract][Full Text] [Related]
18. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line. Zhao C; Setrerrahmane S; Xu H Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272 [TBL] [Abstract][Full Text] [Related]
19. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft. Kong M; Fan J; Dong A; Cheng H; Xu R Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038 [TBL] [Abstract][Full Text] [Related]
20. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients. de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]